KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $45.8 million.

  • Bio-Rad Laboratories' Capital Expenditures rose 675.99% to $45.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $157.6 million, marking a year-over-year decrease of 483.09%. This contributed to the annual value of $157.6 million for FY2025, which is 483.09% down from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Capital Expenditures of $45.8 million as of Q4 2025, which was up 675.99% from $31.7 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Rad Laboratories' Capital Expenditures peaked at $56.2 million during Q4 2021, and registered a low of $17.3 million during Q2 2022.
  • In the last 5 years, Bio-Rad Laboratories' Capital Expenditures had a median value of $35.3 million in 2022 and averaged $36.3 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 3803.64% in 2022, then skyrocketed by 9983.27% in 2023.
  • Over the past 5 years, Bio-Rad Laboratories' Capital Expenditures (Quarter) stood at $56.2 million in 2021, then plummeted by 38.04% to $34.8 million in 2022, then rose by 21.41% to $42.3 million in 2023, then grew by 1.5% to $42.9 million in 2024, then rose by 6.76% to $45.8 million in 2025.
  • Its Capital Expenditures stands at $45.8 million for Q4 2025, versus $31.7 million for Q3 2025 and $45.7 million for Q2 2025.